SomnoMed Limited (ASX:SOM)
0.3350
+0.0050 (1.52%)
Aug 28, 2026, 4:10 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 72.3 million as of August 28, 2026. Its market cap has decreased by -57.24% in one year.
Market Cap
72.30M
Enterprise Value
60.88M
Revenue
114.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
ChartMarket Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 72.30M, an increase of 105.37%. That is a compound annual growth rate of 3.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 72.30M | -57.11% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 160.04M |
| Lumos Diagnostics Holdings | 94.44M |
| Epiminder | 78.97M |
| Cyclopharm | 64.12M |
| Compumedics | 50.94M |
| Cleo Diagnostics | 46.62M |
| HeraMED | 41.67M |